OTCM
UPHL
Market cap1kUSD
Oct 06, Last price
0.00USD
1D
0.00%
1Q
-66.67%
IPO
-100.00%
Name
Uphealth Inc
Chart & performance
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
159m
+28.28%
Net income
-223m
L-34.50%
CFO
-24m
L-61.57%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
UpHealth, Inc. is a company dedicated to providing digital health services. This enterprise delivers patient-centered digital health technologies and technologically advanced services designed to optimize health management and integrate care across various segments, such as comprehensive care coordination, virtual care infrastructure, and associated services. Among its key solutions are the Syntranet Core Platform, which serves as an integrated care management system; Cloudbreak, offering consolidated telemedicine functionalities and digital health resources; HelloLyf from Glocal, a platform enabling primary and specialized medical consultations; and MedQuest Pharmacy, a comprehensive retail and compounding pharmacy licensed to dispatch prescribed medications directly to consumers. The company's main office is situated in Delray Beach, Florida.
Key people
Avishay Katz
Independent Chairman of the Board · since 2022
Jay Jennings
Acting Chief Executive Officer, Chief Financial Officer · since 2024
Jeremy Livianu
Chief Legal Officer and Secretary · since 2024
Director · since 2022
Director · since 2022
Independent Director · since 2021
James Greene
Independent Director · since 2023
Independent Director · since 2022
Independent Director · since 2022
Independent Director · since 2021
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
2479 E. Bayshore Road
Suite 200
Palo Alto, CA 94303
US
Suite 200
Palo Alto, CA 94303
US
Previous name
GIGCAPITAL2, INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||
Revenues | ||||
Cost of revenue | ||||
Unusual Expense (Income) | ||||
NOPBT | ||||
NOPBT Margin | ||||
Operating Taxes | ||||
Tax Rate | ||||
NOPAT | ||||
Net income | ||||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | ||||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | ||||
| Cash flow | ||||
Cash from operating activities | ||||
CAPEX | ||||
Cash from investing activities | ||||
Cash from financing activities | ||||
FCF | ||||
| Balance | ||||
Cash | ||||
Long term investments | ||||
Excess cash | ||||
Stockholders' equity | ||||
Invested Capital | ||||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | ||||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | ||||
EV/EBITDA | ||||
Interest | ||||
Interest/NOPBT | ||||